{
    "clinical_study": {
        "@rank": "18212", 
        "arm_group": [
            {
                "arm_group_label": "Esperimental", 
                "arm_group_type": "Experimental", 
                "description": "Test drug : Granules, Chung A Won 3g (Eucommiaceae, Psoralea corylifolia, Walnut, Ginger) Three times a day, oral administration for 24weeks"
            }, 
            {
                "arm_group_label": "Placebo comparator", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Reference drug : Granules, Placebo 3g (Lactose hydrate, Corn starch, Caramel pigment) Three times a day, oral administration for 24weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "A randomized, Single center, double blind, parallel, placebo-controlled, clinical study of\n      efficacy and safety of Chung A Won and placebo for 24 weeks three times a day on the\n      improvement of osteoporosis and symptoms in Women's older than 50 patients with osteoporosis"
        }, 
        "brief_title": "Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diseases of the Musculo-skeletal System and Connective Tissue", 
            "Osteoporosis"
        ], 
        "condition_browse": {
            "mesh_term": "Osteoporosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female more than 50 years old\n\n          -  Clnical diagnosis of osteoporosis\n\n        Exclusion Criteria:\n\n          -  Wash out peroid\n\n          -  Subject who takes drugs that may affect the clinical trials (Corticosteroids, a\n             nticonvulsants, tranquilizers, antidepressants, hypnotic, diuretic)\n\n          -  Subject who has a chronic liver disease, thyroid disease and chronic renal disease\n\n          -  Pregnant woman\n\n          -  Subject who is not calibrated hypercalcemia/hypocalcemia\n\n          -  Secondary osteoporosis : Subject who takes drugs(Glucocorticoid, Diabetes\n             Medications)\n\n          -  Subject who has 60% more fracture risk in FRAX(WHO fracture risk assessment tool)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "106", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01771510", 
            "org_study_id": "B110051"
        }, 
        "intervention": {
            "arm_group_label": [
                "Esperimental", 
                "Placebo comparator"
            ], 
            "description": "Test drug : Granules, Chung A Won 3g (Eucommiaceae, Psoralea corylifolia, Walnut, Ginger) Three times a day, oral administration for 24weeks\nReference drug : Granules, Placebo 3g (Lactose hydrate, Corn starch, Caramel pigment)\nThree times a day, oral administration for 24weeks", 
            "intervention_name": "Granules, Chung A Won 3g (Eucommiaceae, Psoralea corylifolia, Walnut, Ginger)", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 16, 2013", 
        "location": {
            "contact": {
                "email": "bluesounds@hanmail.net", 
                "last_name": "Eun Jo", 
                "phone": "82-41-521-7031"
            }, 
            "facility": {
                "address": {
                    "city": "Cheonan", 
                    "country": "Korea, Republic of", 
                    "state": "Chungcheongnam-do", 
                    "zip": "331-957"
                }, 
                "name": "Cheonan Oriental Hospital of Daejeon University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Single Center, Double Blind, Parallel, Placebo-controlled Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis", 
        "overall_contact": {
            "email": "lh2000@dju.ac.kr", 
            "last_name": "hyun Lee", 
            "phone": "82-41-521-7578"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in T-score of bone mineral density(QCT) at 24 weeks", 
            "safety_issue": "Yes", 
            "time_frame": "baseline, After 24 weeks(\u00b1 3 days) from the baseline of the trial"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01771510"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ministry of Health & Welfare, Korea", 
            "investigator_full_name": "hyun Lee", 
            "investigator_title": "Cheonan Oriental Hospital of Daejeon University", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in T-score of bone mineral density(QCT)", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, After 4 weeks, 12 weeks from the baseline of the trial"
            }, 
            {
                "measure": "The change of osteoporosis-related indicators of blood tests", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, After 4 weeks, 12 weeks, 24 weeks(endpoint) from the baseline of the trial"
            }, 
            {
                "measure": "The change of ODI(Oswestry Disability Index)", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, After 4 weeks, 12 weeks, 24 weeks(endpoint) from the baseline of the trial"
            }, 
            {
                "measure": "The change of QVAS(Quardruple Visual Analog Scale)", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, After 4 weeks, 12 weeks, 24 weeks(endpoint) from the baseline of the trial"
            }, 
            {
                "measure": "The change of kupperman index", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, After 4 weeks, 12 weeks, 24 weeks(endpoint) from the baseline of the trial"
            }, 
            {
                "measure": "The change of shin-huh symptoms", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, After 4 weeks, 12 weeks, 24 weeks(endpoint) from the baseline of the trial"
            }, 
            {
                "measure": "The change of quality of life using SF-36", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, After 4 weeks, 12 weeks, 24 weeks(endpoint) from the baseline of the trial"
            }
        ], 
        "source": "Ministry of Health & Welfare, Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ministry of Health & Welfare, Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}